Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Nissenbaum

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cell|May 28, 2013
New balance in pluripotency: reprogramming with lineage specifiersUri Ben-David, Jonathan Nissenbaum, Nissim Benvenisty
Stem Cell Reports|December 28, 2013
Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cellsJonathan Nissenbaum, Ori Bar-Nur, Eyal Ben-David, et al.
Pain|June 15, 2007
pain2: A neuropathic pain QTL identified on rat chromosome 2Jonathan Nissenbaum, Hagai Shpigler, Anne Pisanté, et al.
Stem Cell Reviews and Reports|May 18, 2012
Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markersBettina Fishman, Hanna Segev, Oded Kopper, et al.
The European Journal of Neuroscience|August 10, 2007
Sex-specific variability and a 'cage effect' independently mask a neuropathic pain quantitative trait locus detected in a whole genome scanMarshall Devor, Amit Gilad, Michal Arbilly, et al.
Cell Proliferation|April 22, 2023
Genome-wide screen for anticancer drug resistance in haploid human embryonic stem cellsEmanuel Segal, Jonathan Nissenbaum, Mordecai Peretz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Overdominant quantitative trait loci for yield and fitness in tomatoYaniv Semel, Jonathan Nissenbaum, Naama Menda, et al.
Cell Proliferation|November 10, 2024
Predicting tumour resistance to paclitaxel and carboplatin utilising genome-wide screening in haploid human embryonic stem cellsJonathan Nissenbaum, Emanuel Segal, Hagit Philip, et al.
Cell Proliferation|January 15, 2025
Genome-Wide Screening in Haploid Stem Cells Reveals Synthetic Lethality Targeting MLH1 and TP53 Deficient TumoursRivki Cashman, Guy Haim-Abadi, Elyad Lezmi, et al.
Genome Research|August 7, 2010
Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2Jonathan Nissenbaum, Marshall Devor, Ze'ev Seltzer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cell|May 28, 2013
New balance in pluripotency: reprogramming with lineage specifiersUri Ben-David, Jonathan Nissenbaum, Nissim Benvenisty
Stem Cell Reports|December 28, 2013
Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cellsJonathan Nissenbaum, Ori Bar-Nur, Eyal Ben-David, et al.
Pain|June 15, 2007
pain2: A neuropathic pain QTL identified on rat chromosome 2Jonathan Nissenbaum, Hagai Shpigler, Anne Pisanté, et al.
Stem Cell Reviews and Reports|May 18, 2012
Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markersBettina Fishman, Hanna Segev, Oded Kopper, et al.
The European Journal of Neuroscience|August 10, 2007
Sex-specific variability and a 'cage effect' independently mask a neuropathic pain quantitative trait locus detected in a whole genome scanMarshall Devor, Amit Gilad, Michal Arbilly, et al.
Cell Proliferation|April 22, 2023
Genome-wide screen for anticancer drug resistance in haploid human embryonic stem cellsEmanuel Segal, Jonathan Nissenbaum, Mordecai Peretz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Overdominant quantitative trait loci for yield and fitness in tomatoYaniv Semel, Jonathan Nissenbaum, Naama Menda, et al.
Cell Proliferation|November 10, 2024
Predicting tumour resistance to paclitaxel and carboplatin utilising genome-wide screening in haploid human embryonic stem cellsJonathan Nissenbaum, Emanuel Segal, Hagit Philip, et al.
Cell Proliferation|January 15, 2025
Genome-Wide Screening in Haploid Stem Cells Reveals Synthetic Lethality Targeting MLH1 and TP53 Deficient TumoursRivki Cashman, Guy Haim-Abadi, Elyad Lezmi, et al.
Genome Research|August 7, 2010
Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2Jonathan Nissenbaum, Marshall Devor, Ze'ev Seltzer, et al.
Pageof 1